IL125747A0 - T cells mediating an immune response and methods of use - Google Patents

T cells mediating an immune response and methods of use

Info

Publication number
IL125747A0
IL125747A0 IL12574797A IL12574797A IL125747A0 IL 125747 A0 IL125747 A0 IL 125747A0 IL 12574797 A IL12574797 A IL 12574797A IL 12574797 A IL12574797 A IL 12574797A IL 125747 A0 IL125747 A0 IL 125747A0
Authority
IL
Israel
Prior art keywords
methods
immune response
cells mediating
mediating
cells
Prior art date
Application number
IL12574797A
Other languages
English (en)
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jefferson filed Critical Univ Jefferson
Publication of IL125747A0 publication Critical patent/IL125747A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A61K40/32—T-cell receptors [TCR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4271—Melanoma antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/57—Skin; melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12574797A 1996-10-04 1997-10-02 T cells mediating an immune response and methods of use IL125747A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2700296P 1996-10-04 1996-10-04
PCT/US1997/015741 WO1998014206A1 (en) 1996-10-04 1997-10-02 T cells mediating an immune response and methods of use

Publications (1)

Publication Number Publication Date
IL125747A0 true IL125747A0 (en) 1999-04-11

Family

ID=21835095

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12574797A IL125747A0 (en) 1996-10-04 1997-10-02 T cells mediating an immune response and methods of use

Country Status (7)

Country Link
EP (1) EP0871480A4 (de)
AU (1) AU4976697A (de)
CA (1) CA2242590A1 (de)
IL (1) IL125747A0 (de)
NZ (1) NZ330995A (de)
PL (1) PL328790A1 (de)
WO (1) WO1998014206A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3482199A (en) * 1998-04-09 1999-11-01 Thomas Jefferson University A method of inducing an anti-tumor response against a lung metastasis in a melanoma patient
JP2002513772A (ja) * 1998-05-04 2002-05-14 トーマス・ジェファーソン・ユニバーシティ 腫瘍細胞および抽出物を含む組成物、ならびにそれらの使用方法
AU757980B2 (en) 1999-03-16 2003-03-13 Thomas Jefferson University Hapten-conjugated mammalian cells and methods of making and using thereof
US7297330B2 (en) * 2000-02-04 2007-11-20 Thomas Jefferson University Low dose haptenized tumor cell and tumor cell extract immunotherapy
JP2005528901A (ja) 2002-06-10 2005-09-29 アバクス・テクノロジーズ・インコーポレーテッド ハプテン化腫瘍細胞の凍結保存
WO2005059179A1 (en) * 2003-12-12 2005-06-30 Bayer Pharmaceutical Corporation Methods for prediction and prognosis of cancer, and monitoring cancer therapy
US12247060B2 (en) 2018-01-09 2025-03-11 Marengo Therapeutics, Inc. Calreticulin binding constructs and engineered T cells for the treatment of diseases
JP7554742B2 (ja) 2018-07-03 2024-09-20 マレンゴ・セラピューティクス，インコーポレーテッド 抗ｔｃｒ抗体分子およびその使用
EP3906057A4 (de) * 2019-01-04 2022-09-14 Marengo Therapeutics, Inc. Anti-tcr-antikörpermoleküle und ihre verwendungen
GB2597851B (en) 2019-02-21 2024-05-29 Marengo Therapeutics Inc Antibody molecules that bind to NKP30 and uses thereof
AU2020226893B2 (en) 2019-02-21 2025-02-27 Marengo Therapeutics, Inc. Multifunctional molecules that bind to T cell related cancer cells and uses thereof
GB2609554B (en) 2020-01-03 2025-08-20 Marengo Therapeutics Inc Anti-TCR antibody molecules and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806565A1 (de) * 1988-03-01 1989-09-14 Deutsches Krebsforsch Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
IE922233A1 (en) * 1991-07-10 1993-01-13 Augusto C Ochoa Short-term anti-cd3 stimulation of lymphocytes to increase¹their in vivo activity
DE69533295T3 (de) * 1994-02-16 2009-07-16 The Government Of The United States Of America, As Represented By The Secretary, The Department Of Health And Human Services Melanoma-assoziierte Antigene, Epitope davon und Impstoffe gegen Melanoma
IL122455A0 (en) * 1995-06-07 1998-06-15 Univ Jefferson Hapten modified tumor cell extract and methods of treating or screening for cancer

Also Published As

Publication number Publication date
EP0871480A4 (de) 2001-04-04
AU4976697A (en) 1998-04-24
WO1998014206A1 (en) 1998-04-09
NZ330995A (en) 2000-12-22
PL328790A1 (en) 1999-02-15
CA2242590A1 (en) 1998-04-09
EP0871480A1 (de) 1998-10-21

Similar Documents

Publication Publication Date Title
PL334242A1 (en) Fusion-type protein ob - compositions and methods
IL120079A0 (en) An ultrasound system and methods utilizing same
PL329949A1 (en) Method of obtaining copolymers and mixtures containing them
AU7710198A (en) Single pass lead and method of use
HU9302049D0 (en) Trans-splitting ribosimes and elimination of cells using them
EP0871989A4 (de) Elektrischer und mechanischer verbinder
IL122428A0 (en) Minizymes and minribozymes and uses thereof
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
PL333304A1 (en) Techniques and methods of tuberculosis diagnosis
ZA967654B (en) Electrodes and methods of preparation thereof
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
IL125747A0 (en) T cells mediating an immune response and methods of use
AU5044898A (en) Glycolipid mimics and methods of use thereof
AU7378498A (en) Hybrid ribozymes and methods of use
IL125351A0 (en) Exodus chemokine materials and methods
AU3118297A (en) Sok-1 and methods of use
GB9724377D0 (en) Accumulator circuit and method of use thereof
PL331523A1 (en) Azolotrizines and azolopyrimidines
GB2329812B (en) User interface systems and methods
GB2329749B (en) Digital recording systems and methods
IL124430A0 (en) An envelope and an envelope construction
GB9423372D0 (en) Proteins and their uses
PL328334A1 (en) Preparation and application thereof
AU1882395A (en) Blockers of ion channels and methods of use thereof
GB9523574D0 (en) Method of providing an easy open pack, and pack made thereby